Form 4: MYGN Chief Accounting Officer Reports RSU Tax Withholding

Sentiment:

Insider Transaction Report


Myriad Genetics' Chief Accounting Officer, Natalie Munk, reported the disposition of 962 shares for tax withholding related to restricted stock unit vesting.

Summary

  • Natalie Munk, Chief Accounting Officer of Myriad Genetics Inc. (MYGN), reported a transaction on September 21, 2025.
  • The transaction involved the disposition of 962 shares of common stock.
  • These shares were withheld by the company to cover tax withholding obligations associated with the vesting of restricted stock units granted to the reporting person.
  • The shares were valued at $7.77 each, based on the closing price of Myriad common stock on September 19, 2025.
  • Following this transaction, Natalie Munk beneficially owns 45,167 shares of Myriad Genetics common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction for tax withholding purposes, which is a neutral event and does not indicate any significant positive or negative sentiment regarding the company's performance or prospects.

Positives

  • The vesting of restricted stock units (RSUs) implies that performance or time-based conditions were met, leading to the compensation event for the officer.

Negatives

  • The disposition of shares, while for tax purposes, results in a slight reduction in the officer's direct beneficial ownership.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing reports a routine insider transaction related to executive compensation and tax obligations, which is a standard practice across publicly traded companies and does not reflect broader industry trends or competitive positioning.

Comparison to Industry Standards

  • The practice of withholding shares to satisfy tax obligations upon the vesting of restricted stock units is a common and standard method of managing equity compensation in publicly traded companies across various industries.

Stakeholder Impact

  • Shareholders: Minimal impact, as this is a routine compensation-related transaction and does not reflect a discretionary sale or change in investment thesis by the officer.
  • Employees: Reflects standard equity compensation practices for executives.

Key Dates

DateDescription
09/19/2025Closing price of Myriad common stock used to determine the value of shares withheld for tax obligations.
09/21/2025Date of transaction where shares were disposed for tax withholding.
09/22/2025Date the Form 4 was signed by the reporting person's attorney-in-fact.

Recommendation

hold

This Form 4 reports a routine disposition of shares for tax withholding related to restricted stock unit vesting by a company officer. It does not indicate any change in the officer's investment thesis or the company's fundamentals, thus a 'hold' recommendation is appropriate as it provides no new information to alter an existing investment decision.

Keywords

MYRIAD GENETICS, MYGN, Natalie Munk, Form 4, insider transaction, stock disposition, tax withholding, restricted stock units, RSU

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.